210 results
Page 3 of 11
6-K
EX-99.1
0e2dzmv1q aw8c8
30 May 23
Current report (foreign)
6:11am
6-K
lk32m9t6krii3a4o3
17 May 23
Current report (foreign)
6:02am
6-K
w8wxz5iasf5mp1fqfgum
11 May 23
Current report (foreign)
6:10am
6-K
eyc vseefkom29az
11 May 23
Current report (foreign)
6:07am
6-K
EX-99.1
nqvcsm4xs9m5vpu
11 May 23
Current report (foreign)
6:07am
6-K
EX-99.1
vgl0nht
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
kuu61
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
kuibba8nopfcawe
8 Dec 22
Current report (foreign)
6:46am
6-K
EX-99.1
9r0bf04zxi4no0u4ny
30 Nov 22
Current report (foreign)
6:28am
6-K
hnbkt4sgjcb4flea252f
4 Nov 22
Current report (foreign)
6:01am
6-K
9evbc3wm
27 Oct 22
Current report (foreign)
6:01am
6-K
EX-99.1
289wcchbnen04v
27 Oct 22
Current report (foreign)
6:01am
6-K
llj9ch3grrigrc0vk
14 Oct 22
Current report (foreign)
7:36am
6-K
ouzp6mw6p2kf0uj9negu
4 Oct 22
Current report (foreign)
6:06am
6-K
EX-99.1
7wa53v6c9pszmz3
23 Aug 22
Current report (foreign)
6:13am
6-K
EX-99.1
j6xp4h86mudo09e36f
4 Aug 22
Current report (foreign)
6:07am
6-K
qhf38 hfmbd1
4 Aug 22
Current report (foreign)
6:07am
6-K
wx8wc60ym l5gsro
28 Jul 22
Current report (foreign)
6:09am
6-K
EX-99.1
iptkib1h112
28 Jul 22
Current report (foreign)
6:09am
6-K
l28x7ke
11 Jul 22
Current report (foreign)
6:05am